JOHN DEPIETRO: Open Payments
NPI 1194856120 · MANHASSET, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,909 in 54 payments from 12 companies in 2025. Trend: 2023 $3,439 · 2024 $4,733 · 2025 $2,909
Food & beverage: $2,909
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 17 | $1,651 |
| ABIOMED | 5 | $255 |
| Alnylam Pharmaceuticals Inc. | 9 | $179 |
| AstraZeneca Pharmaceuticals LP | 8 | $147 |
| Solventum Corporation | 1 | $140 |
| Edwards Lifesciences Corporation | 1 | $125 |
| Merck Sharp & Dohme LLC | 1 | $123 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $71 |
| SCPHARMACEUTICALS INC. | 2 | $50 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, CARDIOMEMS, AMVUTTRA, ASSURITY, AVEIR, V.A.C.ULTA, WINREVAIR, THORATEC HEARTMATE II, LVAS IMPLANT KIT.
Industry payments across NY — which companies pay providers there.
